These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11048370)

  • 1. Casebook: PSA dilemmas.
    Anderson C
    Practitioner; 2000 Sep; 244(1614):739-41, 744, 748. PubMed ID: 11048370
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient education. Prostate cancer.
    Frydenberg M
    Aust Fam Physician; 2003 Jun; 32(6):428. PubMed ID: 12833768
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA testing.
    Frydenberg M
    Aust Fam Physician; 2003 Jun; 32(6):396. PubMed ID: 12833760
    [No Abstract]   [Full Text] [Related]  

  • 4. [The application of complexed PSA and its relative indexes in the diagnosis of prostate cancer].
    Chen ZH; Zhao J; Wu JM; Xiao CG
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):36-9. PubMed ID: 12680329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary view of prostate cancer diagnosis and treatment.
    Costello AJ
    Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.
    Mitchell ID; Croal BL; Dickie A; Cohen NP; Ross I
    J Urol; 2001 May; 165(5):1549-53. PubMed ID: 11342915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient education. PSA: pros and cons.
    Gattellari M; Ward JE
    Aust Fam Physician; 2003 Jun; 32(6):429-30. PubMed ID: 12833769
    [No Abstract]   [Full Text] [Related]  

  • 8. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
    Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J
    Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
    Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of PSA-density: analysis in PSA gray zone cases].
    Ishizuka O; Iwata K; Igawa Y; Nishizawa O
    Hinyokika Kiyo; 2001 Sep; 47(9):611-3. PubMed ID: 11692595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of PSA screening. Early detection of prostate cancer.
    Pickles T
    Can Fam Physician; 2004 Jan; 50():57-63. PubMed ID: 14761105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
    Kiran PR
    Aust Fam Physician; 2001 May; 30(5):458-60. PubMed ID: 11432019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The search for better markers for prostate cancer than prostate-specific antigen].
    Schenk-Braat EA; Bangma CH
    Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1286-90. PubMed ID: 16821452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing patients about the PSA test: a new requirement.
    Wise P; Duke K
    West J Med; 1998 Sep; 169(3):166-7. PubMed ID: 9771156
    [No Abstract]   [Full Text] [Related]  

  • 17. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer.
    Ashley T
    J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen kinetics in localized and advanced prostate cancer.
    Fitzpatrick JM; Banu E; Oudard S
    BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer.
    Harris M
    Aust Fam Physician; 2003 Jun; 32(6):395. PubMed ID: 12833759
    [No Abstract]   [Full Text] [Related]  

  • 20. [PSA doubling times of prostate carcinoma managed with watchful observation alone].
    Dunst J
    Strahlenther Onkol; 2001 Dec; 177(12):684-5. PubMed ID: 11789411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.